China Pharma Holdings Revenue 2010-2025 | CPHI
China Pharma Holdings revenue from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
China Pharma Holdings Annual Revenue
(Millions of US $) |
| 2024 |
$5 |
| 2023 |
$7 |
| 2022 |
$8 |
| 2021 |
$10 |
| 2020 |
$11 |
| 2019 |
$11 |
| 2018 |
$12 |
| 2017 |
$13 |
| 2016 |
$16 |
| 2015 |
$20 |
| 2014 |
$22 |
| 2013 |
$33 |
| 2012 |
$55 |
| 2011 |
$81 |
| 2010 |
$74 |
| 2009 |
$62 |
China Pharma Holdings Quarterly Revenue
(Millions of US $) |
| 2025-03-31 |
$1 |
| 2024-12-31 |
$1 |
| 2024-09-30 |
$1 |
| 2024-06-30 |
$1 |
| 2024-03-31 |
$1 |
| 2023-12-31 |
$2 |
| 2023-09-30 |
$2 |
| 2023-06-30 |
$1 |
| 2023-03-31 |
$2 |
| 2022-12-31 |
$3 |
| 2022-09-30 |
$2 |
| 2022-06-30 |
$2 |
| 2022-03-31 |
$2 |
| 2021-12-31 |
$3 |
| 2021-09-30 |
$2 |
| 2021-06-30 |
$2 |
| 2021-03-31 |
$2 |
| 2020-12-31 |
$3 |
| 2020-09-30 |
$2 |
| 2020-06-30 |
$4 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
$3 |
| 2019-09-30 |
$2 |
| 2019-06-30 |
$3 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
$3 |
| 2018-09-30 |
$2 |
| 2018-06-30 |
$3 |
| 2018-03-31 |
$4 |
| 2017-12-31 |
$4 |
| 2017-09-30 |
$3 |
| 2017-06-30 |
$3 |
| 2017-03-31 |
$3 |
| 2016-12-31 |
$5 |
| 2016-09-30 |
$3 |
| 2016-06-30 |
$4 |
| 2016-03-31 |
$4 |
| 2015-12-31 |
$5 |
| 2015-09-30 |
$4 |
| 2015-06-30 |
$6 |
| 2015-03-31 |
$6 |
| 2014-12-31 |
$3 |
| 2014-09-30 |
$6 |
| 2014-06-30 |
$6 |
| 2014-03-31 |
$7 |
| 2013-12-31 |
$8 |
| 2013-09-30 |
$8 |
| 2013-06-30 |
$8 |
| 2013-03-31 |
$8 |
| 2012-12-31 |
$12 |
| 2012-09-30 |
$12 |
| 2012-06-30 |
$15 |
| 2012-03-31 |
$16 |
| 2011-12-31 |
$22 |
| 2011-09-30 |
$21 |
| 2011-06-30 |
$20 |
| 2011-03-31 |
$18 |
| 2010-12-31 |
$24 |
| 2010-09-30 |
$19 |
| 2010-06-30 |
$17 |
| 2010-03-31 |
$15 |
| 2009-12-31 |
$20 |
| 2009-09-30 |
$16 |
| 2009-06-30 |
$14 |
| 2009-03-31 |
$13 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.006B |
$0.005B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
